Home › Final Phase 1 data of zoptarelin doxorubicin Phase 1/2 trial published in Clinical Cancer Research
 

Keywords :   


Final Phase 1 data of zoptarelin doxorubicin Phase 1/2 trial published in Clinical Cancer Research

2014-12-31 15:50:06| Logistics - Topix.net

Aeterna Zentaris Inc. today announced that an article on final data for the Phase 1 portion of the ongoing Phase 1/2 trial in prostate cancer with zoptarelin doxorubicin , a hybrid molecule composed of a synthetic peptide carrier and a well-known chemotherapy agent, doxorubicin, has been published in the December issue of Clinical Cancer Research . The article outlines data previously disclosed in June 2013 at the American Society of Clinical Oncology's Annual Meeting, which demonstrated the compound's safety profile and promising anti-tumor activity in heavily pretreated men with castration- and taxane-resistant prostate cancer.

Tags: data research final published

Category:Transportation and Logistics

Latest from this category

All news
16.11Eastern North Pacific Tropical Weather Outlook
16.11Atlantic Tropical Weather Outlook
16.11Tropical Storm Sara Graphics
16.11Summary for Tropical Storm Sara (AT4/AL192024)
16.11Tropical Storm Sara Public Advisory Number 9A
15.11Tropical Storm Sara Forecast Discussion Number 9
15.11Tropical Storm Sara Wind Speed Probabilities Number 9
15.11Summary for Tropical Storm Sara (AT4/AL192024)
Transportation and Logistics »
16.11CD
16.11 SwitchEL+ ()
16.11
16.11rac lt nspro 950gh S
16.11Switch --
16.11
16.114
16.11
More »